Insiders · TDAC

Michael B Hoffman

Chairman and CEO, Director at Translational Development Acquisition Corp. (TDAC) since December 2024

Michael B Hoffman has filed 22 insider reports with the SEC since July 2021, as director at Annovis Bio, Inc. (ANVS) and chairman and CEO and director at Translational Development Acquisition Corp. (TDAC). In the last 12 months Michael B Hoffman bought $7M of stock on the open market. In the latest filing, on November 6, 2026, Michael B Hoffman bought 5,000,000 shares of Annovis Bio, Inc. (ANVS) for $5M at an average of $1.00.

Filings
22
Companies
2
Bought on market
$9.1M
Sold on market
None

Companies where Michael B Hoffman is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Annovis Bio, Inc. logo
ANVS
Annovis Bio, Inc.
Director8,364,883$9.1M$1.32$0.7113-46%Nov 6, 2026
Translational Development Acquisition Corp. logo
TDAC
Translational Development Acquisition Corp.
Chairman and CEO, Directorsince December 2024$10.92May 29, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.

Every filing

Compare Michael B Hoffman with

Other insiders at the same companies

Questions about Michael B Hoffman

What is Michael B Hoffman's role at Translational Development Acquisition Corp.?
Michael B Hoffman reports to the SEC as chairman and CEO and director at Translational Development Acquisition Corp. (TDAC), according to the latest filing on May 29, 2026. Michael B Hoffman has also filed as director at Annovis Bio, Inc. (ANVS).
How many shares does Michael B Hoffman own?
After the latest filing that states it, Michael B Hoffman directly owned 8,364,883 shares of Annovis Bio, Inc. (ANVS). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Michael B Hoffman bought or sold stock recently?
The most recent open-market purchase was on November 6, 2026: bought 5,000,000 shares of Annovis Bio, Inc. (ANVS) for $5M at an average of $1.00.
How do I get alerts when Michael B Hoffman files?
Follow Michael B Hoffman on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Michael B Hoffman filed 1 time in the last 90 days.

From SEC Forms 3, 4, 5 and 144 filed by Michael B Hoffman (SEC CIK 0001290208). Totals count each trade once, skipping amendments whose original is on file, from Jul 9, 2021 on. View on SEC EDGAR · Get this as JSON